Recurrent Endometrial Cancer Recruiting Phase 1 Trials for Paclitaxel (DB01229)

Also known as: Endometrial cancer recurrent / Cancer of endometrium recurrent / Ca endometrium recurrent / Endometrial carcinoma recurrent / Carcinoma endometrial recurrent

IndicationStatusPhase
DBCOND0054384 (Recurrent Endometrial Cancer)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02788708Lenvatinib and Weekly Paclitaxel for Patients With Recurrent Endometrial or Ovarian CancerTreatment